-
Information-Publications
-
Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer modelsDetails -
Celastrol alleviates subconjunctival fibrosis induced by silicone implants mimicking glaucoma surgeryDetails -
Dysregulation of iron homeostasis by TfR-1 renders EZH2 wild type diffuse large B-cell lymphoma resistance to EZH2 inhibitionDetails -
Luhong Formula and Hydroxysafflor yellow A protect cardiomyocytes by inhibiting autophagyDetails -
Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibitionDetails -
The foam cell-derived exosomes exacerbate ischemic white matter injury via transmitting metabolic defects to microgliaDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
Back
